Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2.

Zhao WT, Lin XL, Liu Y, Han LX, Li J, Lin TY, Shi JW, Wang SC, Lian M, Chen HW, Sun Y, Xu K, Jia JS, Luo RC, Xiao D.

Lab Invest. 2019 Jun 14. doi: 10.1038/s41374-019-0270-5. [Epub ahead of print]

PMID:
31201367
2.

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.

Ma DN, Chai ZT, Zhu XD, Zhang N, Zhan DH, Ye BG, Wang CH, Qin CD, Zhao YM, Zhu WP, Cao MQ, Gao DM, Sun HC, Tang ZY.

J Hematol Oncol. 2016 Jan 6;9:1. doi: 10.1186/s13045-015-0229-y.

3.

miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.

Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y.

Genet Test Mol Biomarkers. 2015 Jan;19(1):30-6. doi: 10.1089/gtmb.2014.0245.

PMID:
25494962
4.

miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2.

Yu L, Lu J, Zhang B, Liu X, Wang L, Li SY, Peng XH, Xu X, Tian WD, Li XP.

Oncol Lett. 2013 Apr;5(4):1223-1228. Epub 2013 Feb 4.

5.

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.

Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX.

Hepatology. 2013 Jul;58(1):158-70. doi: 10.1002/hep.26305. Epub 2013 Jun 5.

PMID:
23389848
6.

The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.

Ma Y, Deng F, Li P, Chen G, Tao Y, Wang H.

Biomed Pharmacother. 2018 May;101:648-655. doi: 10.1016/j.biopha.2018.02.118. Epub 2018 Mar 22.

PMID:
29518611
7.

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.

Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF, Li XP.

Cancer Res. 2011 Jan 1;71(1):225-33. doi: 10.1158/0008-5472.CAN-10-1850.

8.

MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.

Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, Wang F, Zhang CY, Zen K, Li L.

Cell Death Dis. 2017 Jan 12;8(1):e2540. doi: 10.1038/cddis.2016.461.

9.

MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.

Zhang X, Zhang X, Wang T, Wang L, Tan Z, Wei W, Yan B, Zhao J, Wu K, Yang A, Zhang R, Jia L.

Cancer Lett. 2018 Jul 10;426:98-108. doi: 10.1016/j.canlet.2018.04.005. Epub 2018 Apr 11.

PMID:
29653269
10.

MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.

Chai ZT, Kong J, Zhu XD, Zhang YY, Lu L, Zhou JM, Wang LR, Zhang KZ, Zhang QB, Ao JY, Wang M, Wu WZ, Wang L, Tang ZY, Sun HC.

PLoS One. 2013 Oct 23;8(10):e77957. doi: 10.1371/journal.pone.0077957. eCollection 2013.

11.

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, Xu K.

Biochim Biophys Acta. 2012 Nov;1822(11):1692-704. doi: 10.1016/j.bbadis.2012.07.019. Epub 2012 Aug 4.

12.

MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis.

Li Y, Ren M, Zhao Y, Lu X, Wang M, Hu J, Lu G, He S.

Oncol Rep. 2017 Jun;37(6):3527-3535. doi: 10.3892/or.2017.5579. Epub 2017 Apr 19.

PMID:
28440439
13.

Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.

Jiang FZ, He YY, Wang HH, Zhang HL, Zhang J, Yan XF, Wang XJ, Che Q, Ke JQ, Chen Z, Tong H, Zhang YL, Wang FY, Li YR, Wan XP.

Oncotarget. 2015 Dec 29;6(42):44660-74. doi: 10.18632/oncotarget.6350.

14.

The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.

Cabello P, Pineda B, Tormo E, Lluch A, Eroles P.

Int J Mol Sci. 2016 Aug 10;17(8). pii: E1298. doi: 10.3390/ijms17081298.

15.

PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.

Tian T, Nan KJ, Guo H, Wang WJ, Ruan ZP, Wang SH, Liang X, Lu CX.

Oncol Rep. 2010 Jun;23(6):1593-600.

PMID:
20428814
16.

A double-negative feedback loop between EZH2 and miR-26a regulates tumor cell growth in hepatocellular carcinoma.

Zhuang C, Wang P, Huang D, Xu L, Wang X, Wang L, Hu L.

Int J Oncol. 2016 Mar;48(3):1195-204. doi: 10.3892/ijo.2016.3336. Epub 2016 Jan 13.

PMID:
26781064
17.

MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.

Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH, Qin LX.

Hepatology. 2014 May;59(5):1874-85. doi: 10.1002/hep.26941. Epub 2014 Apr 1.

PMID:
24259426
18.

LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis.

Zhang M, Duan W, Sun W.

Onco Targets Ther. 2019 May 2;12:3349-3360. doi: 10.2147/OTT.S197433. eCollection 2019.

19.

MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.

Huang B, Huang M, Li Q.

Pathol Res Pract. 2018 Dec;214(12):1980-1986. doi: 10.1016/j.prp.2018.08.005. Epub 2018 Aug 8.

PMID:
30274685
20.

MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.

Zhang X, Cheng SL, Bian K, Wang L, Zhang X, Yan B, Jia LT, Zhao J, Gammoh N, Yang AG, Zhang R.

Oncotarget. 2015 Feb 10;6(4):2277-89.

Supplemental Content

Support Center